Celiac Disease Insurance Claims Denied: How to Appeal

Celiac disease is an autoimmune condition triggered by gluten exposure that causes intestinal damage, malabsorption, and a range of serious complications. Despite being a well-established diagnosis with clear diagnostic criteria and management guidelines, celiac disease patients frequently face insurance denials for diagnostic testing, specialist care, and nutritional management. This guide explains the common denial scenarios and how to fight back.

Common Celiac Disease Claim Denial Scenarios

Small Bowel Biopsy: Duodenal biopsy via upper endoscopy is the gold standard for celiac disease diagnosis. Insurers may deny this as not medically necessary when positive serologic testing (anti-tTG IgA, anti-endomysial antibody) has already been obtained — arguing that serology alone is sufficient for diagnosis. However, the American College of Gastroenterology (ACG) guidelines and the American Society for Gastrointestinal Endoscopy (ASGE) standards support biopsy for definitive diagnosis, for evaluating other pathologies, and for assessing the degree of villous atrophy that guides management intensity.

Serologic Testing Denials: Repeated serologic testing used for monitoring adherence to a gluten-free diet and mucosal healing may be denied as excessive or not medically necessary. Monitoring labs are a standard part of celiac management and their necessity can be documented with physician letters citing ACG follow-up guidelines.

Dietitian Counseling: The gluten-free diet is the only treatment for celiac disease and is complex enough to require professional guidance. Registered dietitian counseling is covered as preventive care under the ACA for certain conditions, but coverage in celiac disease specifically depends on how the plan codes the visit. Denials often result from coding issues (preventive vs. medical nutrition therapy billing) rather than a substantive coverage exclusion.

Medical Nutrition Therapy (MNT): Under the ACA, MNT provided by a registered dietitian is covered without cost-sharing for certain conditions. While celiac disease is not specifically enumerated in the ACA MNT mandate (which focuses on diabetes and chronic kidney disease), many plans cover MNT for GI conditions, and coverage arguments can be made under "chronic disease management" benefit language.

Gluten-Free Medical Foods: Specially formulated gluten-free medical foods (prescribed by a physician) are covered in some states and some plans, but coverage varies significantly. Most standard commercial plans do not cover gluten-free food as a medical benefit. However, specialized elemental formulas or nutritional supplements prescribed for celiac patients with significant malabsorption or refractory celiac disease may qualify for coverage as medical nutrition products.

Capsule Endoscopy: For patients with suspected refractory celiac disease or complications (e.g., small bowel lymphoma surveillance), capsule endoscopy may be ordered but denied as not medically necessary.

Building Your Celiac Disease Appeal

For biopsy denials:

• Your gastroenterologist should document the specific clinical questions that biopsy will answer beyond what serology provides
• Note that serologic testing may be false negative in IgA-deficient patients
• Cite ACG Clinical Guidelines on celiac disease which recommend biopsy for definitive diagnosis in adults
• Document any diagnostic uncertainty or comorbid conditions (e.g., lymphocytic colitis, microscopic colitis, Crohn's disease) that require pathologic differentiation

For dietitian coverage denials:

• Distinguish between preventive nutrition counseling and medical nutrition therapy (MNT) billing codes (97802, 97803)
• If your dietitian billed as preventive, confirm whether celiac disease qualifies under your plan's preventive care schedule
• Have your gastroenterologist include a referral for MNT with a letter stating the therapeutic necessity of dietary counseling in celiac disease management

For monitoring lab denials:

• Document the clinical rationale: monitoring adherence, assessing mucosal healing, adjusting management intensity
• Cite ACG follow-up guidelines recommending repeat serologic testing at 6 and 12 months and periodically thereafter
• Document any abnormal results or ongoing symptoms that make more frequent monitoring necessary

For medical nutrition product denials:

• If the patient has malabsorption requiring specialized formula, have the prescribing physician document the medically necessary nutritional formulation and why standard food cannot meet the patient's nutritional requirements
• Check whether your state has a medical food mandate

State-Specific Protections

A small number of states have laws requiring insurance coverage for medical foods and special dietary products for conditions requiring dietary management. Check your state's insurance department or a celiac patient advocacy organization for state-specific rules.

Fight Back With ClaimBack

Celiac disease management is not optional — the consequences of untreated disease are serious. ClaimBack helps you build the documentation and argument to get the coverage you need.

Start your celiac disease insurance appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter That Gets Results
• What Is Medical Necessity — and How to Prove It to Your Insurer
• Common Reasons Insurance Claims Are Denied